Effect of angiotensin-converting enzyme insertion/deletion genotype on collagen type I synthesis and degradation in patients with atrial fibrillation and arterial hypertension.

Biohealthmatics.com - Search our database for Health Informatics Journals, Healthcare IT Journals, Bioinformatics Journals and Biotechnology Journals.

Sign Up

Biohealthmatics Centers

Home

Jobs Search

Career Center

Networking Center

Company Profiles

Knowledge Center

Industry News

Web Directory

Industry Books

Effect of angiotensin-converting enzyme insertion/deletion genotype on collagen type I synthesis and degradation in patients with atrial fibrillation and arterial hypertension.

Tziakas DN, Chalikias GK, Stakos DA, Papazoglou D, Papanas N, Papatheodorou K, Chatzikyriakou SV, Kotsiou S, Maltezos E, Boudoulas H.

Democritus University of Thrace, University Cardiology Department, Voulgaroktonou 23, Alexandroupolis 68100, Greece. dtziakas@med.duth.gr

Publication Date: Thursday, October 11, 2007

Click here to view MEDLINE citation

More October, 2007 pharmacogenomics journal articles.

Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics.

GPCR NaVa database: natural variants in human G protein-coupled receptors.

Alcoholism and alcohol drinking habits predicted from alcohol dehydrogenase genes.

[Targeted therapy: what does it mean? A physician point of view]

Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues.

Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism.

Pharmacogenomics in clinical trials: An analysis.

Pharmacogenomics - The potential of genetically guided prescribing.

Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI.

Pharmacogenomics research involving racial classification: qualitative research findings on researchers' views, perceptions and attitudes towards socioethical responsibilities.

Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.

Colorectal cancer therapeutics and the challenges of applied pharmacogenomics.

The Pharmacogenetics of Major Depression: Past, Present, and Future.

Phase II pharmacogenomics-based adjuvant therapy trial in patients with non-small-cell lung cancer: Southwest Oncology Group Trial 0720.

Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme-an in silico approach.

The pharmacogenetics of analgesia.

Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy.

Future relevance of genetic testing: A systematic horizon scanning analysis.

Pharmacogenetics of acute lymphoblastic leukemia treatment response.

More pharmacogenomics journal articles ...

Last Updated: 7 August 2006.